Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: dermal
Type of information:
experimental study
Adequacy of study:
key study
Study period:
30 Nov-14 Dec 1988
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Guideline study with acceptable restrictions. The test substance (a solid) was applied under occlusive conditions.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1988
Report date:
1988

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 402 (Acute Dermal Toxicity)
Version / remarks:
adopted in February 1987
Deviations:
yes
Remarks:
exposure under occlusive conditions
GLP compliance:
yes
Test type:
standard acute method
Limit test:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
-
EC Number:
404-740-9
EC Name:
-
Cas Number:
115895-09-5
Molecular formula:
C26H40Cl2O5
IUPAC Name:
ethyl 3,5-dichloro-4-{[(hexadecyloxy)carbonyl]oxy}benzoate
Details on test material:
- Name of test material (as cited in study report): AF-366
- Physical state: white powder
- Analytical purity: no data

Test animals

Species:
rat
Strain:
other: Wistar outbred (Bor:WISW)
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Breeding Centre for Laboratory Animals, F. Winkelmann GmbH, Borchen, Germany
- Age at study initiation: approximately 19 weeks
- Weight at study initiation: 310-360 g (males), 190-230 g (females)
- Housing: before dosing, the rats were housed in groups of five per sex, in stainless steel cages with a wire-screen bottom and front. After dosing, the rats were housed individually in stainless steel cages with a wire-screen bottom and front.
- Diet: CIVO cereal-based, open-formula diet for rats, ad libitum
- Water: tap water, ad libitum
- Acclimation period: approximately 14 weeks

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22-24
- Humidity (%): 40-60
- Air changes (per hr): 10
- Photoperiod (hrs dark / hrs light): 12/12

IN-LIFE DATES: From: 30 Nov 1988 To: 14 Dec 1988

Administration / exposure

Type of coverage:
occlusive
Vehicle:
maize oil
Details on dermal exposure:
TEST SITE
- Area of exposure: the dorsal and ventral clipped area of the trunk of the animals
- Type of wrap if used: the test material was held in contact with the skin with a plastic film, which was secured by an elastic adhesive bandage (Tensoplast) around the trunk of the rat

REMOVAL OF TEST SUBSTANCE
- Washing (if done): the residual test material was cleaned from the treated area with water
- Time after start of exposure: 24 h

TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 8 mL/kg bw
- For solids, paste formed: no, a suspension was prepared

VEHICLE
- Amount(s) applied (volume or weight with unit): 8 mL/kg bw
- Concentration (if solution): 75%
Duration of exposure:
24 h
Doses:
2000 mg/kg bw
No. of animals per sex per dose:
5
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: observations of clinical signs were made several times on Day 0 (post-administration) until 4 hours after dosing and daily thereafter; weighing was performed on Day 0 (pre-administration), 3, 7 and 14; skin irritation effects were assessed on Day 1, 3 and 7
- Necropsy of survivors performed: yes, all gross pathological changes were recorded
- Other examinations performed: clinical signs, mortality, skin irritation

Results and discussion

Effect levels
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 2 000 mg/kg bw
Based on:
test mat.
Mortality:
There was no mortality during the 14-day study period (see Table 1).
Clinical signs:
other: 5/5 males and 5/5 females were moderately sluggish from 1 up to 4 hours after administration of the test substance. Piloerection was observed at the 24-hour reading time point only, in 5/5 males and 5/5 females (see Table 1).
Gross pathology:
No treatment-related effects were observed during the gross pathological examination.
Other findings:
- Other observations: there were no skin irritation effects following exposure to the test substance

Any other information on results incl. tables

Table 1: Mortality and clinical signs

Dose
[mg/kg bw]

Toxicological results*

Duration of clinical signs

Time of death

Mortality (%)

Males

2000

0/5/5

1-24 h 

-

0

Females

2000

0/5/5

1-24 h 

-

0

Overall LD50 > 2000 mg/kg bw

* first number = number of dead animals                                 

 second number = number of animals with systemic clinical signs         

 third number = number of animals used                               

 

Table 2: Individual and mean body weight changes

Body weight (g)

 

Day 0

Day 3

Day 7

Day 14

Males

1

344

333

346

354

2

310

304

320

328

3

350

342

363

375

4

358

352

354

354

5

360

360

361

372

Mean body weight, males (g)

344

338

349

357

 

6

228

223

223

220

7

190

180

190

180

8

230

221

204

221

9

203

200

208

201

10

196

193

193

196

Mean body weight, females (g)

209

203

204

204

Applicant's summary and conclusion

Interpretation of results:
not classified
Remarks:
Migrated information Criteria used for interpretation of results: EU
Conclusions:
CLP: not classified
DSD: not classified